Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

Clinical trial NCT02158520 · COMPLETED

Trial details

NCT number: NCT02158520
Sponsor: Academic and Community Cancer Research United
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma Mucosal Melanoma Stage IV Cutaneous Melanoma AJCC v6 and v7 Stage IV Uveal Melanoma AJCC v7 Unresectable Melanoma

Start date: 2013-10-18
Primary completion: 2017-05-24
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.